These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 5060669

  • 1. Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease.
    Acocella G, Bonollo L, Garimoldi M, Mainardi M, Tenconi LT, Nicolis FB.
    Gut; 1972 Jan; 13(1):47-53. PubMed ID: 5060669
    [Abstract] [Full Text] [Related]

  • 2. Single dose kinetics of rifampicin and isoniazid in well-nourished and malnourished patients of tuberculosis.
    Garg SK, Dhand R, Malik SK, Kalra S, Gupta PH, Jha VK, Shukla VK, Lal R.
    Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):417-20. PubMed ID: 3220617
    [Abstract] [Full Text] [Related]

  • 3. [Urinary excretion of rifampicin in kidney failure when administered alone or together with isoniazid].
    Titarenko OT, Vakhmistrova TI, Perova TL.
    Antibiotiki; 1983 Sep; 28(9):698-702. PubMed ID: 6638984
    [Abstract] [Full Text] [Related]

  • 4. Serum concentrations and bioavailability of rifampicin and isoniazid in combination.
    Garnham JC, Taylor T, Turner P, Chasseaud LF.
    Br J Clin Pharmacol; 1976 Oct; 3(5):897-902. PubMed ID: 973984
    [Abstract] [Full Text] [Related]

  • 5. A metabolic and kinetic study on the association rifampicin-isoniazid.
    Acocella G.
    Respiration; 1971 Oct; 28():Suppl:1-6. PubMed ID: 4948628
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacodynamic interference between rifampicin and isoniazid.
    Llorens J, Serrano RJ, Sanchez R.
    Chemotherapy; 1978 Oct; 24(2):97-103. PubMed ID: 620612
    [Abstract] [Full Text] [Related]

  • 7. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels.
    Agrawal S, Singh I, Kaur KJ, Bhade SR, Kaul CL, Panchagnula R.
    Int J Pharm; 2004 May 19; 276(1-2):41-9. PubMed ID: 15113612
    [Abstract] [Full Text] [Related]

  • 8. [Pharmacokinetic interaction of ketoconazole, isoniazid and rifampicin].
    Pilheu JA, Galati MR, Yunis AS, De Salvo MC, Negroni R, García Fernández JC, Mingolla L, Rubio MC, Masana M, Acevedo C.
    Medicina (B Aires); 1989 May 19; 49(1):43-7. PubMed ID: 2698437
    [Abstract] [Full Text] [Related]

  • 9. Bioavailability of isoniazid, rifampicin and pyrazinamide (in free combination or fixed-triple formulation) in intermittent antituberculous chemotherapy.
    Acocella G, Luisetti M, Grassi GG, Peona V, Pozzi E, Grassi C.
    Monaldi Arch Chest Dis; 1993 May 19; 48(3):205-9. PubMed ID: 8369784
    [Abstract] [Full Text] [Related]

  • 10. [Plasma levels of rifampicin and isoniazid and serum levels of aminotransferases in combined tuberculostatic treatment (author's transl)].
    Knop P, Kindler U, Austerhoff A.
    Dtsch Med Wochenschr; 1977 Dec 30; 102(52):1913-5. PubMed ID: 598300
    [Abstract] [Full Text] [Related]

  • 11. Studies on blood serum levels of rifampicin in patients with normal and impaired liver function.
    Curci G, Claar E, Bergamini N, Ninni A, Claar GM, Ascione A, Nitti V.
    Chemotherapy; 1973 Oct 30; 19(4):197-205. PubMed ID: 4772959
    [No Abstract] [Full Text] [Related]

  • 12. Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations.
    Panchagnula R, Singh I, Kaur KJ, Kaul CL.
    Methods Find Exp Clin Pharmacol; 1999 Nov 30; 21(9):625-8. PubMed ID: 10669909
    [Abstract] [Full Text] [Related]

  • 13. Bioavailability of rifampicin, isoniazid and pyrazinamide in a triple drug formulation: comparison of plasma and urine kinetics.
    Gurumurthy P, Ramachandran G, Vijayalakshmi S, Kumar AK, Venkatesan P, Chandrasekaran V, Vjayasekaran V, Kumaraswami V, Prabhakar R.
    Int J Tuberc Lung Dis; 1999 Feb 30; 3(2):119-25. PubMed ID: 10091876
    [Abstract] [Full Text] [Related]

  • 14. Bioavailability of rifampicin, isoniazid and pyrazinamide from fixed-dose combination capsules.
    Zwolska Z, Niemirowska-Mikulska H, Augustynowicz-Kopec E, Walkiewicz R, Stambrowska H, Safianowska A, Grubek-Jaworska H.
    Int J Tuberc Lung Dis; 1998 Oct 30; 2(10):824-30. PubMed ID: 9783530
    [Abstract] [Full Text] [Related]

  • 15. Serum concentrations of rifampicin and isoniazid in tuberculosis.
    Seth V, Beotra A, Seth SD, Semwal OP, Kabra S, Jain Y, Mukhopadhya S.
    Indian Pediatr; 1993 Sep 30; 30(9):1091-8. PubMed ID: 8125594
    [Abstract] [Full Text] [Related]

  • 16. Rifampicin blood serum levels and half-life during prolonged administration in tuberculous patients.
    Nitti V, Delli Veneri F, Ninni A, Meola G.
    Chemotherapy; 1972 Sep 30; 17(2):121-9. PubMed ID: 4558400
    [No Abstract] [Full Text] [Related]

  • 17. Oral bioavailability of rifampicin, isoniazid, ethambutol, and pyrazinamide in a 4-drug fixed-dose combination compared with the separate formulations in healthy Chinese male volunteers.
    Xu J, Jin H, Zhu H, Zheng M, Wang B, Liu C, Chen M, Zhou L, Zhao W, Fu L, Lu Y.
    Clin Ther; 2013 Feb 30; 35(2):161-8. PubMed ID: 23410999
    [Abstract] [Full Text] [Related]

  • 18. Use of liver function tests as predictors of rifampicin metabolism in cirrhosis.
    McConnell JB, Powell-Jackson PR, Davis M, Williams R.
    Q J Med; 1981 Feb 30; 50(197):77-82. PubMed ID: 7267969
    [Abstract] [Full Text] [Related]

  • 19. Marked enhancement by rifampicin and lack of effect of isoniazid on the elimination of quinine in man.
    Wanwimolruk S, Kang W, Coville PF, Viriyayudhakorn S, Thitiarchakul S.
    Br J Clin Pharmacol; 1995 Jul 30; 40(1):87-91. PubMed ID: 8527275
    [Abstract] [Full Text] [Related]

  • 20. [Antibacterian activity modifications of serum isoniazid when using it with rifampicin (author's transl)].
    Nouhouayi A, Bergogne-Berezin E, Lafaix C.
    Pathol Biol (Paris); 1982 Jun 30; 30(6):389-93. PubMed ID: 7050848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.